Sacroiliac joint fusion

Sacroiliac joint fusion is a surgical treatment sometimes used to address pain that may be originating from the joint between bones in the spine and hip (sacrum and ilium). The sacroiliac joint (SIJ) is a diarthrodial joint with two surfaces and a fibrous capsule containing synovial fluid. 

Sacroiliac joint fusion was first reviewed by the HTA program in 2019.

  • In 2020, a review of sacroiliac joint fusion medical literature was conducted to determine if newly available published evidence could change the original coverage determination. 
  • In 2021, the HCA director selected sacroiliac joint fusion for rereview based on newly available published evidence that could change the original coverage determination.

Status: Decision completed

Why is sacroiliac joint fusion being reviewed?

The Washington Health Technology Assessment program (HTA) selected Sacroiliac joint fusion as a topic for assessment because of high concerns for safety, efficacy and cost.

Primary criteria ranking

  • Safety = High
  • Efficacy = High
  • Cost  = High

Documentation

Assessment timeline 

  • Draft key questions published: January 26, 2021

    • Public comment period: January 26 to February 11, 2021

  • Final key questions published: February 25, 2021

  • Draft report published: April 2, 2021

    • Public comment period: April 2 to  May 3, 2021

  • Final report published: May 19, 2021

  • HTCC public meeting: June 18, 2021